Cargando…

Imaging P‐Glycoprotein Function at the Blood–Brain Barrier as a Determinant of the Variability in Response to Central Nervous System Drugs

Detalles Bibliográficos
Autores principales:	Bauer, Martin, Tournier, Nicolas, Langer, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491962/ https://www.ncbi.nlm.nih.gov/pubmed/30903694 http://dx.doi.org/10.1002/cpt.1402

Ejemplares similares

Pathways for Small Molecule Delivery to the Central Nervous System Across the Blood-Brain Barrier
por: Mikitsh, John L, et al.
Publicado: (2014)

Decreased blood-brain barrier P-glycoprotein function with aging
por: Bauer, Martin, et al.
Publicado: (2008)

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [(11)C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
por: Breuil, Louise, et al.
Publicado: (2022)

Blood extracellular vesicles (EVs) of central nervous system origin: a window into the brain
por: Agliardi, Cristina, et al.
Publicado: (2019)

Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography
por: Wanek, Thomas, et al.
Publicado: (2015)

Sortilins in the blood-brain barrier: impact on barrier integrity
por: Toth, Andrea E., et al.
Publicado: (2022)

Factors That Limit Positron Emission Tomography Imaging of P-Glycoprotein Density at the Blood–Brain Barrier
por: Kannan, Pavitra, et al.
Publicado: (2013)

Comparison of the Blood–Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug–Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging
por: Breuil, Louise, et al.
Publicado: (2022)

Blood-brain barrier modeling: challenges and perspectives
por: Ruck, Tobias, et al.
Publicado: (2015)

Astrocytes dynamically regulate the blood-brain barrier in the healthy brain
por: Pociūtė, Agnė, et al.
Publicado: (2023)

Vascular inflammation in the central nervous system
por: Guo, Xinying, et al.
Publicado: (2022)

Bioengineering an Artificial Human Blood–Brain Barrier in Rodents
por: Kamal, Kimia, et al.
Publicado: (2019)

Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning
por: Morofuji, Yoichi, et al.
Publicado: (2020)

Multiple hurdle mechanism and blood-brain barrier in epilepsy: glucocorticoid receptor-heat shock proteins on drug regulation
por: Achar, Aneesha, et al.
Publicado: (2021)

Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET
por: Bauer, Martin, et al.
Publicado: (2010)

Characterization of the blood brain barrier in pediatric central nervous system neoplasms
por: Hong, Christopher S., et al.
Publicado: (2016)

Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
por: Rhea, Elizabeth M., et al.
Publicado: (2019)

Central Nervous System Histoplasmosis: An Updated Insight
por: Ramírez, José Antonio, et al.
Publicado: (2023)

Acid sphingomyelinase-mediated blood-brain barrier disruption in aging
por: Park, Min Hee, et al.
Publicado: (2019)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Brain-on-a-Chip: Characterizing the next generation of advanced in vitro platforms for modeling the central nervous system
por: Maoz, Ben M.
Publicado: (2021)

Resolving the age-related decline in central nervous system myelin turnover and drug discovery for oligodendroglial rejuvenation
por: Rivera, Andrea Domenico, et al.
Publicado: (2022)

Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice
por: Biali, Myriam El, et al.
Publicado: (2023)

Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study
por: Bauer, Martin, et al.
Publicado: (2015)

Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model
por: Roux, Gwenaëlle Le, et al.
Publicado: (2019)

The role of interleukin-6 in central nervous system demyelination
por: Petković, Filip, et al.
Publicado: (2016)

Chronic oligodendrocyte injury in central nervous system pathologies
por: Molina-Gonzalez, Irene, et al.
Publicado: (2022)

Are claudin-5 tight-junction proteins in the blood-brain barrier porous?
por: Fisher, David, et al.
Publicado: (2020)

Metabolomic profiling provides new insights into blood-brain barrier regulation
por: Huang, Sheng-Fu, et al.
Publicado: (2021)

Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood–brain barriers studied with (R)-[(11)C]verapamil positron emission tomography
por: Müllauer, Julia, et al.
Publicado: (2012)

Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases
por: Rice, Olivia, et al.
Publicado: (2022)

Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke
por: Brzica, Hrvoje, et al.
Publicado: (2017)

Self-healing hydrogel for tissue repair in the central nervous system
por: Hsieh, Fu-Yu, et al.
Publicado: (2015)

Neuroprotective role of galectin-1 in central nervous system pathophysiology
por: Aalinkeel, Ravikumar, et al.
Publicado: (2016)

The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer's disease
por: Dias, Irundika HK, et al.
Publicado: (2022)

Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease?
por: Petrovskaya, Aleksandra, et al.
Publicado: (2023)

Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study
por: Conti, Allegra, et al.
Publicado: (2022)

How do corticosteroids influence myelin genesis in the central nervous system?
por: Chari, Divya M.
Publicado: (2014)

Collagen 1 signaling at the central nervous system injury site and astrogliosis
por: Neo, Sin Hui, et al.
Publicado: (2017)

CXCR4 signaling in central nervous system regeneration: friend or foe?
por: Terheyden-Keighley, Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6jo8u10r1ruauarsh9lbc013ad